Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10555 |
BJE6-106
B106 |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
BJE6-106 (B106) is a potent, selective PKCδ inhibitor (IC50: 0.05 μM) and targets selectivity over classical PKCα (IC50: 50 μM). BJE6-106 induces caspase-dependent apoptosis with tumor-specific effect. |